Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease
Atherosclerosis (AS) is a lipid-driven chronic inflammatory disease occurring at the arterial subendothelial space. Macrophages play a critical role in the initiation and development of AS. Herein, targeted codelivery of anti-miR 155 and anti-inflammatory baicalein is exploited to polarize macrophag...
Saved in:
Main Authors: | Chao Teng (Author), Chenshi Lin (Author), Feifei Huang (Author), Xuyang Xing (Author), Shenyu Chen (Author), Ling Ye (Author), Helena S. Azevedo (Author), Chenjie Xu (Author), Zhengfeng Wu (Author), Zhongjian Chen (Author), Wei He (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artesunate alleviates the inflammatory response of ulcerative colitis by regulating the expression of miR-155
by: Zhao-Bin Yang, et al.
Published: (2021) -
miR-155 in the Resolution of Atherosclerosis
by: Robyn Bruen, et al.
Published: (2019) -
Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells
by: Han S, et al.
Published: (2015) -
Preparation of a miR-155-activating nucleic acid nanoflower to study the molecular mechanism of miR-155 in inflammation
by: Wenxin Wang, et al.
Published: (2022) -
Expression pattern of miR-193a, miR122, miR155, miR-15a, and miR146a in peripheral blood mononuclear cells of children with obesity and their relation to some metabolic and inflammatory biomarkers
by: Maryam Behrooz, et al.
Published: (2023)